Trevena

Trevena’s Investigator-Led RELIEVE Study Accepted for Presentation at 2024 American Burn Association Meeting

CHESTERBROOK, PA — Biopharmaceutical company Trevena, Inc. (Nasdaq: TRVN), known for its innovative work in developing and commercializing novel medicines for central nervous system disorders, recently announced the acceptance of …

Trevena’s Investigator-Led RELIEVE Study Accepted for Presentation at 2024 American Burn Association Meeting Read More

Ocugen

Ocugen CEO to Address Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company specializing in the discovery, development, and commercialization of gene and cell therapies, biologics, and vaccines, has announced that its Chairman, …

Ocugen CEO to Address Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference Read More

Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in non-opioid pain management therapies, has announced significant changes to its leadership team amidst ongoing litigation. The company recently …

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman Read More

TELA Bio

TELA Bio to Showcase Innovations at Piper Sandler’s 35th Annual Healthcare Conference

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a frontrunner in the medical technology industry, has announced its participation in Piper Sandler’s 35th Annual Healthcare Conference. The commercial-stage company is …

TELA Bio to Showcase Innovations at Piper Sandler’s 35th Annual Healthcare Conference Read More